Stefan

Good to see responsible interpretation of the data

StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data NEWARK, Calif., May 31, 2016 (GLOBE NEWSWIRE) — StemCells, Inc. (NASDAQ: STEM) (the “Company”) today announced its decision to terminate the Company’s Phase II Pathway Study in…

Read More

MSK’s Lorenz Studer Named a 2015 MacArthur Fellow

MacArthur Foundation Lorenz Studer is a stem cell biologist pioneering the large-scale generation of dopaminergic neurons for transplantation, a breakthrough that could provide treatment for Parkinson’s disease and, eventually, other neurodegenerative diseases. Parkinson’s, caused by the death of dopamine-generating cells…

Read More